Biocon is a mid cap company in the health sector, whose share price is currently looking very attractive. Today we are giving you Biocon Share Price Target for upcoming years.
If you are also interested in pharma sector companies, then Biocon company can definitely be studied. So in this article we will look at the business model of Biocon Limited in detail. Also we will discuss Biocon Share Price Target 2023, 2024, 2025, 2026, 2030 or Biocon Share Target Price.
Also Read This : Tata Power Share Price Target 2023, 2024, 2025, 2026, 2030 and 2040
Overview Of Biocon Company
Biocon Limited is a publicly traded biopharmaceutical company based in India. The company specializes in the development, manufacture, and marketing of biopharmaceuticals, including biosimilars, recombinant proteins, and monoclonal antibodies. Biocon also offers contract research and manufacturing services to other biotech companies. The company was founded in 1978 by Kiran Mazumdar-Shaw, and is headquartered in Bengaluru, India. Biocon is also one of the largest biotechnology company in India and Asia.
- Company Name: Biocon Limited
- Industry: Biopharmaceuticals
- Founded: 1978
- Founder: Kiran Mazumdar-Shaw
- Headquarters: Bengaluru, India
- Specialization: Development, manufacture, and marketing of biopharmaceuticals, including biosimilars, recombinant proteins, and monoclonal antibodies
- Additional Services: Contract research and manufacturing services to other biotech companies
- Company Size: One of the largest biotechnology company in India and Asia
Biocon Share Price Target 2023
This Company is a midcap company which has been working in the pharma sector for a very long time. Biocon Limited is engaged in the business of manufacturing biotechnology products and research services.
Talking about the business of Biocon Limited, it is quite different from other pharmaceutical companies. Mostly this company manufactures medicines for rare diseases, whose demand is seen more in the market. The company is constantly looking to increase its market share in this segment.
Biocon is a leading Biopharma company in India with a track record of 40 years. In the Biopharma segment, the company primarily has its presence in India and semi-regulated economies. The first target for Biocon Share Price Target 2023 can be seen at ₹282 while the second target can be achieved at ₹300.
Biocon Share Price Target 2024
If we talk about the company’s revenue segments, then biologics make up 41% of the revenue while research services make up 31%. The remaining 28% of the remaining revenue comes from small generic products.
In this way, good diversification is seen in Biocon’s revenue. The company has completed 34 product filings for APIs globally, including the U.S. includes 28 filings for five more formulations, 11 of which were in the US.
Biocon’s long-term growth potential will be led by its biosimilars and novel biologics segments in the semi-regulated and regulated markets. While these sectors require huge investments in R&D and capital expenditure. In this, the company is supported by stable cash flows from all its established business segments – generics, biosimilars and research services.
The first target for Biocon Share Price Target 2024 can be seen at ₹321 while the second target can be at ₹333.
Also Read This : Coal India Share Price Target 2023, 2024, 2025 and 2030
Biocon Share Price Target 2025
Biocon has strong R&D capability and several biosimilar and new biologic products in development in the diabetes, oncology and autoimmune therapeutic segments.
The company is continuously increasing its products which can increase the revenue of Biocon in the coming times.
The company’s capacity expansion projects include an API manufacturing facility in Visakhapatnam in the first half of FY2023. In addition, work has commenced on a new synthetic API plant at the Hyderabad facility as well as a new injectable plant at Biocon Park, Bengaluru.
In this way we can see that the management is constantly taking steps to grow its business. The first target for Biocon Share Price Target 2025 can be ₹ 370. The same level of ₹ 403 can be achieved as the second target.
Also read This : Reliance Power Share Price Target 2023, 2024, 2025 and 2030
Biocon Share Price Target 2026
The financials of the company are also sound and there is a lot of scope for improvement. Biocon’s management is in dire need of focusing on the company’s revenue and profits.
Biocon Limited is gradually trying to increase its market share in the domestic market as well as focusing on the international market. Presently the company has its presence in around 120 countries. Here the company exports about 17% of its total production.
For this, Biocon Management has also taken approval from different organizations to launch many new products in the international market to increase the volume of exports. With this it can be expected that there can be a good increase in the exports of the company in the coming times.
The first target for Biocon Share Price Target 2026 can be ₹435. The level of ₹450 can be achieved as the second target.
Also Share This : SBI Share Price Target 2022, 2023, 2025, 2030, 2050
Biocon Share Price Target 2030
The business model of the company is looking good in the long term. But there are also some threats of investment in Biocon Share which can create problems in the coming times.
As this company is working in a highly regulated market. If there are some adverse changes in it, then the company may be in trouble. Secondly, there is a lot of competition in the pharma sector. To stay ahead in this competition, Biocon has to make continuous efforts.
Also, whenever a pharma company makes a product with hard work and heavy investment, after that approval of many institutions has to be taken to launch the product in the market. If for some reason the product is not approved, then the company may have to bear huge losses. Also may have to lose market share
The first target for Biocon Share Price Target 2030 can be seen at ₹613 while the second target can be achieved at ₹635.
Business model of Biocon company
Financial Strength of company
- The company is virtually a debt free business.
- The company has a healthy interest coverage ratio of 350.25.
- There is an efficient cash conversion cycle of 69.20 days.
- high liquidity available
- High Promoters Holding.
- The company has good operating leverage, with an average operating leverage of 3.09.
- Established position in the Biopharma segment.
- Strong and diversified revenue segments.
- A healthy pipeline of biosimilar products.
- The company has shown poor profit growth of -44.09% in last 3 years.
- Biocon has shown poor revenue growth of -15.62% for the last 3 years.
- The company has a poor ROE (Return on Equity) of 3.61% in the last 3 years.
- Has a poor ROCE of 4.67% in the last 3 years.
Competitors of Biocon
The following companies are the market competitors of Biocon Company:
- Torrent Pharma
- Zydus Lifescience
- Alkem Laboratories
- Gland Pharma
Biocon Share Price Target 2023, 2024, 2025, 2026, 2030
|Biocon Share Price Forecast|
|First Target (2023)||₹282|
|First Target (2024)||₹321|
|First Target (2025)||₹370|
|First Target (2026)||₹435|
|First Target (2030)||₹613|
The business of Pharma companies is very rotational. It is a bit difficult to get continuous growth in these. Biocon was also doing very well till recently. But the company’s performance has been erratic in the last few years.
So friends, today we have discussed Biocon Share Price Target 2023, 2024, 2025, 2026 and 2030. Friends, if you liked this information, please share it with your companions on social media networks. Your valuable suggestions are invited in the below comment box.
No investment advice has been given in this post, these posts have been written for educational purpose. We are not SEBI Registered Advisor. Please do your own research or seek the advice of your financial advisor before making any investment. Do not buy stocks just by looking at the stock target.